Mucin 1 Market Report

Global and Region Mucin 1 Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：203
  • REPORT CODE：GMM937500
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Mucin 1 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Mucin 1market, defines the market attractiveness level of Mucin 1 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Mucin 1 industry, describes the types of Mucin 1 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Mucin 1 market and the development prospects and opportunities of Mucin 1 industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Mucin 1 market in Chapter 13.

    By Player:

    • Boehringer Ingelheim GmbH

    • Etubics Corp

    • Bavarian Nordic A/S

    • GeoVax Labs Inc

    • Transgene SA

    • Merck KGaA

    • Minerva Biotechnologies Corp

    • Vaxil Bio Therapeutics Ltd

    • Akshaya Bio Inc

    By Type:

    • TG-4010

    • GO-2032c

    • ImMucin

    • BI-1361849

    • Others

    By End-User:

    • Prostate Cancer

    • Breast Cancer

    • Colon Cancer

    • Ovarian Cancer

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Mucin 1 Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Mucin 1 Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Mucin 1 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Mucin 1 Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Mucin 1 Market Analysis and Outlook to 2022

    • 7.1 Global Mucin 1 Consumption (2017-2022)

    • 7.2 United States Mucin 1 Consumption (2017-2022)

    • 7.3 Europe Mucin 1 Consumption (2017-2022)

    • 7.4 China Mucin 1 Consumption (2017-2022)

    • 7.5 Japan Mucin 1 Consumption (2017-2022)

    • 7.6 India Mucin 1 Consumption (2017-2022)

    • 7.7 South Korea Mucin 1 Consumption (2017-2022)

    8 Region and Country-wise Mucin 1 Market Analysis and Outlook to 2028

    • 8.1 Global Mucin 1 Consumption Forecast (2022-2028)

    • 8.2 United States Mucin 1 Consumption Forecast (2022-2028)

    • 8.3 Europe Mucin 1 Consumption Forecast (2022-2028)

    • 8.4 China Mucin 1 Consumption Forecast (2022-2028)

    • 8.5 Japan Mucin 1 Consumption Forecast (2022-2028)

    • 8.6 India Mucin 1 Consumption Forecast (2022-2028)

    • 8.7 South Korea Mucin 1 Consumption Forecast (2022-2028)

    9 Global Mucin 1 Market Outlook by Types and Applications to 2022

    • 9.1 Global Mucin 1 Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global TG-4010 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global GO-2032c Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global ImMucin Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global BI-1361849 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Mucin 1 Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Colon Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Ovarian Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Mucin 1 Market Outlook by Types and Applications to 2028

    • 10.1 Global Mucin 1 Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global TG-4010 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global GO-2032c Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global ImMucin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global BI-1361849 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Mucin 1 Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Colon Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Mucin 1 Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Mucin 1 Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Mucin 1 Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Mucin 1 Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Mucin 1 Market Competitive Analysis

    • 14.1 Boehringer Ingelheim GmbH

      • 14.1.1 Boehringer Ingelheim GmbH Company Details

      • 14.1.2 Boehringer Ingelheim GmbH Mucin 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Boehringer Ingelheim GmbH Mucin 1 Product and Service

    • 14.2 Etubics Corp

      • 14.2.1 Etubics Corp Company Details

      • 14.2.2 Etubics Corp Mucin 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Etubics Corp Mucin 1 Product and Service

    • 14.3 Bavarian Nordic A/S

      • 14.3.1 Bavarian Nordic A/S Company Details

      • 14.3.2 Bavarian Nordic A/S Mucin 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bavarian Nordic A/S Mucin 1 Product and Service

    • 14.4 GeoVax Labs Inc

      • 14.4.1 GeoVax Labs Inc Company Details

      • 14.4.2 GeoVax Labs Inc Mucin 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 GeoVax Labs Inc Mucin 1 Product and Service

    • 14.5 Transgene SA

      • 14.5.1 Transgene SA Company Details

      • 14.5.2 Transgene SA Mucin 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Transgene SA Mucin 1 Product and Service

    • 14.6 Merck KGaA

      • 14.6.1 Merck KGaA Company Details

      • 14.6.2 Merck KGaA Mucin 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Merck KGaA Mucin 1 Product and Service

    • 14.7 Minerva Biotechnologies Corp

      • 14.7.1 Minerva Biotechnologies Corp Company Details

      • 14.7.2 Minerva Biotechnologies Corp Mucin 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Minerva Biotechnologies Corp Mucin 1 Product and Service

    • 14.8 Vaxil Bio Therapeutics Ltd

      • 14.8.1 Vaxil Bio Therapeutics Ltd Company Details

      • 14.8.2 Vaxil Bio Therapeutics Ltd Mucin 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Vaxil Bio Therapeutics Ltd Mucin 1 Product and Service

    • 14.9 Akshaya Bio Inc

      • 14.9.1 Akshaya Bio Inc Company Details

      • 14.9.2 Akshaya Bio Inc Mucin 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Akshaya Bio Inc Mucin 1 Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Mucin 1

    • Figure Mucin 1 Picture

    • Table Global Mucin 1 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Mucin 1 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Mucin 1 Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Mucin 1 Consumption by Country (2017-2022)

    • Figure United States Mucin 1 Consumption and Growth Rate (2017-2022)

    • Table Europe Mucin 1 Consumption and Growth Rate (2017-2022)

    • Figure China Mucin 1 Consumption and Growth Rate (2017-2022)

    • Figure Japan Mucin 1 Consumption and Growth Rate (2017-2022)

    • Figure India Mucin 1 Consumption and Growth Rate (2017-2022)

    • Figure South Korea Mucin 1 Consumption and Growth Rate (2017-2022)

    • Figure Global Mucin 1 Consumption Forecast by Country (2022-2028)

    • Figure United States Mucin 1 Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Mucin 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Mucin 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Mucin 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Mucin 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Mucin 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global TG-4010 Consumption and Growth Rate (2017-2022)

    • Figure Global GO-2032c Consumption and Growth Rate (2017-2022)

    • Figure Global ImMucin Consumption and Growth Rate (2017-2022)

    • Figure Global BI-1361849 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Colon Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Ovarian Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global TG-4010 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global GO-2032c Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ImMucin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BI-1361849 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colon Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Mucin 1 Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Mucin 1 Export by Region (Top 5 Countries) (2017-2028)

    • Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim GmbH Mucin 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim GmbH Mucin 1 Product and Service

    • Table Etubics Corp (Foundation Year, Company Profile and etc.)

    • Table Etubics Corp Mucin 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Etubics Corp Mucin 1 Product and Service

    • Table Bavarian Nordic A/S (Foundation Year, Company Profile and etc.)

    • Table Bavarian Nordic A/S Mucin 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bavarian Nordic A/S Mucin 1 Product and Service

    • Table GeoVax Labs Inc (Foundation Year, Company Profile and etc.)

    • Table GeoVax Labs Inc Mucin 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table GeoVax Labs Inc Mucin 1 Product and Service

    • Table Transgene SA (Foundation Year, Company Profile and etc.)

    • Table Transgene SA Mucin 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Transgene SA Mucin 1 Product and Service

    • Table Merck KGaA (Foundation Year, Company Profile and etc.)

    • Table Merck KGaA Mucin 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck KGaA Mucin 1 Product and Service

    • Table Minerva Biotechnologies Corp (Foundation Year, Company Profile and etc.)

    • Table Minerva Biotechnologies Corp Mucin 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Minerva Biotechnologies Corp Mucin 1 Product and Service

    • Table Vaxil Bio Therapeutics Ltd (Foundation Year, Company Profile and etc.)

    • Table Vaxil Bio Therapeutics Ltd Mucin 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vaxil Bio Therapeutics Ltd Mucin 1 Product and Service

    • Table Akshaya Bio Inc (Foundation Year, Company Profile and etc.)

    • Table Akshaya Bio Inc Mucin 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Akshaya Bio Inc Mucin 1 Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US